ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2695

Host Genetic Background Disrupts The Relationship Between Microbiota and Gut Mucosal Tolerance Leading To Spondyloarthritis and Ileitis After a Dectin-1 Trigger

Linda Rehaume1, Stanislas Mondot2, Daniel Aguirre de Cárcer2, Jared Velasco1, Helen Benham1, Sumaira Hasnain3, Jaclyn Bowman1, Merja Ruutu1, Philip Hansbro4, Michael McGuckin3, Mark Morrison2 and Ranjeny Thomas1, 1University of Queensland Diamantina Institute, Brisbane, Australia, 2CSIRO Livestock Industries, Brisbane, Australia, 3Mater Medical Research Institute, Brisbane, Australia, 4Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, Newcastle, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Crohn's Disease, ER Stress, interleukins (IL), microbiome and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Chronic inflammatory diseases known as spondyloarthropathies (SpA) including ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and arthritis associated with inflammatory bowel disease, collectively affect 3% of the population, and are strongly heritable. Consistent with shared clinical features and genetic associations, the pathology of each disease is associated with microorganisms, and flares in bowel symptoms correlate with arthritic and spondylitic activity. However, it is not clear how the microbiome influences disease expression in SpA and how this relates to host genetic background. We sought to understand this in BALB/c wild type and ZAP-70W163C (SKG) point-mutant mice with reduced T cell receptor signaling.

Methods:

SKG and BALB/c mice housed under specific pathogen-free (SPF) or germ-free (GF) conditions were injected intraperitoneally with microbial 1,3-D beta-glucan (curdlan). Arthritis, spondylitis and ileitis were assessed histologically. Microbiome composition in serial fecal samples of mice cohoused from weaning was analyzed by 454 pyrosequencing.

Results:

By analysis 8 weeks after curdlan, pathological severity of arthritis, spondylitis and ileitis depended on both genetic background and microbiome. Under SPF conditions, SKG mice developed severe spondylitis, arthritis and ileitis whereas curdlan-treated BALB/c developed mild arthritis and spondylitis, but no ileitis. Under GF conditions, SKG mice had reduced spondyloarthritis incidence and no ileitis. Thus development of ileitis was most sensitive to genetic background and associated microbiome i.e. absent in GF SKG mice and SPF BALB/c mice, highest incidence and severity in SPF SKG and intermediate in GF SKG mice colonized with a limited bacterial consortium. Initiation of ileal IL-23 expression, ER stress, depletion of goblet cells and IL-17 response in draining lymph nodes depended on presence of the microbiome. By pyrosequencing, microbiome content in turn depended on the genetic background of the host and the microbial response to beta-glucan over time. Consistent with transmissible suppressive microbes in BALB/c feces, ileitis but not arthritis or spondylitis severity was reduced in SKG cohoused with BALB/c mice. 

Conclusion:

Our data are consistent with impaired microbial homeostasis in SKG hosts where T cells express ZAP70W163C, and provide a molecular basis for understanding the relationship between immune genetic susceptibility and development of SpA in response to an inflammatory environmental trigger, through host genetic effects on the gut microbiome. Modification of the microbiome presents a novel prophylatic strategy to attenuate genetic risk of SpA.


Disclosure:

L. Rehaume,
None;

S. Mondot,
None;

D. Aguirre de Cárcer,
None;

J. Velasco,
None;

H. Benham,
None;

S. Hasnain,
None;

J. Bowman,
None;

M. Ruutu,
None;

P. Hansbro,
None;

M. McGuckin,
None;

M. Morrison,
None;

R. Thomas,

Janssen Pharmaceutica Product, L.P.,

2,

UCB,

5,

Abbott Laboratories,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/host-genetic-background-disrupts-the-relationship-between-microbiota-and-gut-mucosal-tolerance-leading-to-spondyloarthritis-and-ileitis-after-a-dectin-1-trigger/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology